Fonteyne V - Search Results

1

Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.

Bamias A, Stenzl A, Brown SL, Albiges L, Babjuk M, Birtle A, Briganti A, Burger M, Choudhury A, Colecchia M, De Santis M, Fanti S, Fonteyne V, Gallucci M, Rivas JG, Huddart R, Junker K, Kroeze S, Loriot Y, Merseburger A, Montironi R, Necchi A, Oing C, Oldenburg J, Ost P, Pinkawa M, Ribal MJ, Rouprêt M, Thoeny H, Zilli T, Hoskin P. Bamias A, et al. Among authors: fonteyne v. Eur Urol. 2023 Oct;84(4):381-389. doi: 10.1016/j.eururo.2023.05.005. Epub 2023 May 20. Eur Urol. 2023. PMID: 37217391

2

Prostate magnetic resonance spectroscopic imaging at 1.5tesla with endorectal coil versus 3.0tesla without endorectal coil: comparison of spectral quality.

De Visschere P, Nezzo M, Pattyn E, Fonteyne V, Van Praet C, Villeirs G. De Visschere P, et al. Among authors: fonteyne v. Clin Imaging. 2015 Jul-Aug;39(4):636-41. doi: 10.1016/j.clinimag.2015.02.008. Epub 2015 Feb 21. Clin Imaging. 2015. PMID: 25735448

3

Is It Safe to Switch from a Standard Anterior to Retzius-Sparing Approach in Robot-Assisted Radical Prostatectomy?

Lambert E, Allaeys C, Berquin C, De Visschere P, Verbeke S, Vanneste B, Fonteyne V, Van Praet C, Lumen N. Lambert E, et al. Among authors: fonteyne v. Curr Oncol. 2023 Mar 17;30(3):3447-3460. doi: 10.3390/curroncol30030261. Curr Oncol. 2023. PMID: 36975474 Free PMC article.

4

Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer. Treatment planning, quality control, and clinical implementation.

Vandecasteele K, De Neve W, De Gersem W, Delrue L, Paelinck L, Makar A, Fonteyne V, De Wagter C, Villeirs G, De Meerleer G. Vandecasteele K, et al. Among authors: fonteyne v. Strahlenther Onkol. 2009 Dec;185(12):799-807. doi: 10.1007/s00066-009-1986-8. Strahlenther Onkol. 2009. PMID: 20013089

5

Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.

Fonteyne V, De Gersem W, De Neve W, Jacobs F, Lumen N, Vandecasteele K, Villeirs G, De Meerleer G. Fonteyne V, et al. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1013-20. doi: 10.1016/j.ijrobp.2008.12.047. Epub 2009 Apr 20. Int J Radiat Oncol Biol Phys. 2009. PMID: 19386427

6

Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Ost P, Fonteyne V, Villeirs G, Lumen N, Oosterlinck W, De Meerleer G. Ost P, et al. Among authors: fonteyne v. Eur Urol. 2009 Oct;56(4):669-75. doi: 10.1016/j.eururo.2009.05.041. Epub 2009 May 29. Eur Urol. 2009. PMID: 19501453

7

A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.

Ost P, De Troyer B, Fonteyne V, Oosterlinck W, De Meerleer G. Ost P, et al. Among authors: fonteyne v. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1316-22. doi: 10.1016/j.ijrobp.2010.04.039. Epub 2010 Aug 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675081

8

High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.

Ost P, Lumen N, Goessaert AS, Fonteyne V, De Troyer B, Jacobs F, De Meerleer G. Ost P, et al. Among authors: fonteyne v. Eur Urol. 2011 Oct;60(4):842-9. doi: 10.1016/j.eururo.2011.04.021. Epub 2011 Apr 16. Eur Urol. 2011. PMID: 21514039

9

Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation.

Vandecasteele K, Ost P, Oosterlinck W, Fonteyne V, Neve WD, Meerleer GD. Vandecasteele K, et al. Among authors: fonteyne v. Phytother Res. 2012 Feb;26(2):208-13. doi: 10.1002/ptr.3528. Epub 2011 Jun 1. Phytother Res. 2012. PMID: 21630361 Clinical Trial.

10

Population screening for prostate cancer: an overview of available studies and meta-analysis.

Lumen N, Fonteyne V, De Meerleert G, Ost P, Villeirs G, Mottrie A, De Visschere P, De Troyer B, Oosterlinck W. Lumen N, et al. Among authors: fonteyne v. Int J Urol. 2012 Feb;19(2):100-8. doi: 10.1111/j.1442-2042.2011.02912.x. Epub 2011 Nov 22. Int J Urol. 2012. PMID: 22103653 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page